IOV-EAP-402: Expanded Access Program of AMTAGVI that is Out of Specification for Commercial Release

Skip to Content

JavaScript has been disabled within your browser, the content or the functionality of this web page can be limited or unavailable.

There is no panel matching the key "Alert---Site-Wide"

Back to Results

IOV-EAP-402: Expanded Access Program of AMTAGVI that is Out of Specification for Commercial Release

Objective

Clinical Trial Details

IRB Protocol Number

2024.067

Clinical Trial Categories

Melanoma

Contact

Medical Oncology Research Coordinators at 605-322-3295
or medoncresearch@avera.org

Location

Avera Cancer Institute — Sioux Falls
1000 E 23rd St
Suite 340
Sioux Falls, SD 57105
Main: 605-322-3000